Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
586K
-
Shares change
-
+226K
-
Total reported value, excl. options
-
$3.37M
-
Value change
-
+$1.29M
-
Number of buys
-
7
-
Number of sells
-
-1
-
Price
-
$5.74
Significant Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q1 2021
8 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share as of Q1 2021.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 586K shares
of 101M outstanding shares and own 0.58% of the company stock.
Largest 8 shareholders include SABBY MANAGEMENT, LLC (418K shares), EMC Capital Management (75.8K shares), CITADEL ADVISORS LLC (36.7K shares), MILLENNIUM MANAGEMENT LLC (35.3K shares), DAVENPORT & Co LLC (15K shares), WOLVERINE ASSET MANAGEMENT LLC (3.08K shares), Tower Research Capital LLC (TRC) (2.02K shares), and UBS Group AG (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.